Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP https://t.co/bzzcWkaRPp via @Pharmaceutical Business review @Gamma_Monkey #stocks #stockmarket #investing #trading #stockmarketnews #news #stocktrading #business #wallstreet #alpha #alphanews